Tagged: brainsway RSS Toggle Comment Threads | Keyboard Shortcuts

  • mayay 4:16 pm on January 1, 2015 Permalink
    Tags: brainsway, brainsway deep tms treatment, brainsway us, depression treatment fda, ,   

    Brainsway Establishes US Subsidiary To Promote Deep TMS Treatment 

    brainsway logoJanuary 1. 2015 | The Israeli company Brainsway, developing a unique treatment for brain disorders, announced that due to increased interest in the United States, it will launch a subsidiary in the US. Brainsway USA is already working towards recruiting key personnel and is working towards building a versatile team of employees that will expand the company in the US. Brainsway develops and markets Deep TMS (Deep Transcranial Magnetic Stimulation) systems for the treatment of brain disorders, a technology based on patents filed with the National Institutes of Health. The use of the company’s technology for the treatment of depression was recently approved by the US Food & Drug Administration.

     
  • mayay 5:13 pm on December 25, 2014 Permalink
    Tags: brainsway, , deep tms therapy, , , uzi sofer   

    Brainsway’s CEO, Uzi Sofer, Steps Down 

    brainsway logoDecember 25, 2014 | The CEO of Brainsway, an Israeli company developing treatments for serious brain disorders, Uzi Sofer will step down from his position. Sofer informed the company and its investors of his decision this morning (Thursday), with the company agreeing that he will end his term at Brainsway in April 2015 after 12 years serving as the head of the company he founded. Sofer will remain the director of the company. Brainsway also announced that it will cut ties with its public relations representatives in the United States, reaching the decision that it will begin its own marketing regime in the US. According to most estimates, the company seeks out an American CEO to replace Sofer that will help the company get on its feet in the US. Recently, the company received FDA approval for the treatment of depression using its Deep TMS System. Brainsway was founded in 2003 by Uzi Sofer, President Avner Hagai and Chairman David Zacut.

     
  • mayay 2:15 pm on October 21, 2014 Permalink
    Tags: brainsway, , brainsway in europe, dTMS, , israel brain stimulation,   

    Brainsway Signs Marketing Agreement With French Co. 

    brainsway logoOctober 21, 2014 | The Israeli company Brainsway has reportedly signed a marketing agreement with a French company for its Deep TMS System in France. Brainsway’s Deep TMS (Deep Transcranial Magnetic Stimulation) system is a treatment for depression and other brain disorders that has been approved by the FDA in the United States for the treatment of severe depression. According to the agreement, Brainsway will deal directly with customers recruited by the French company, while paying the latter company a commission for every new customer. In addition, Brainsway announced that BlueCross BlueShield will begin to reimburse patients for Brainsway treatments in the US states of Flordia, Kansas and Missouri, and that Tufts will do so in Massachusetts.

     
  • NoCamels Team 12:44 pm on October 7, 2013 Permalink | Reply
    Tags: brainsway, , ,   

    Brainsway Raises NIS 24M On TASE 

    Brainsway Raises NIS 24M On TASEOctober 7, 2013 | Israeli company Brainsway, which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has raised NIS 24 million (approx. $6.8 million) on the Tel Aviv Stock Exchange (TASE). The company received an additional $1 million from a Japanese distributer over the weekend.

     
  • NoCamels Team 1:44 pm on May 30, 2013 Permalink | Reply
    Tags: , , , brainsway, , , ,   

    Brainsway’s Deep TMS Treatment Approved By EU 

    Brainsway's Deep TMS Treatment Approved By EUIsraeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), has received the EU’s CE Marketing stamp of approval for its Deep TMS system. The company will use the system for treating autism, Alzheimer’s and cigarette addiction.

    The approval was granted by MedCert, which is qualified for approving medical treatments by CE Marketing. Earlier this year, Brainsway won FDA and Health Canada approval.

     
  • NoCamels Team 12:10 pm on May 1, 2013 Permalink | Reply
    Tags: brainsway, , , ,   

    Brainsway Will Launch Deep TMS In The US 

    Brainsway Will Launch Deep TMS In The USIsraeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), will launch its Deep TMS product in the US this month. The device, which is intended for treatment of major depression, won FDA approval earlier this year.

     
  • NoCamels Team 1:22 pm on January 27, 2013 Permalink | Reply
    Tags: brainsway, , , , ,   

    Brainsway Trial Shows Significant Results For Smoking Addiction Treatment 

    Brainsway Trial Shows Significant Results For Smoking Addiction TreatmentIsraeli company Brainsway, which developed a device called Deep TMS (transcranial magnetic stimulation), for treating various brain-related disorders, has announced a successful trial of its treatment for smoking addiction. 84 percent of subjects in the trial quit smoking after receiving the treatment, of which approx. one-third were still non-smokers after a six month period.

     
  • NoCamels Team 12:20 pm on January 16, 2013 Permalink | Reply
    Tags: , brainsway, , , health canada,   

    Brainsway Receives Health Canada Approval For Depression Treatment 

    Brainsway Receives Health Canada Approval For Depression TreatmentIsraeli company Brainsway Ltd. has received approval from the Health Canada for its Deep TMS treatment. The treatment, approved earlier this month by the American FDA, uses transcranial magnetic stimulation for treating people suffering from depression for whom drug treatment was not effective.

     
  • NoCamels Team 2:00 pm on January 10, 2013 Permalink | Reply
    Tags: , brainsway, , , ,   

    Brainsway’s Deep TMS System Wins FDA Approval 

    Brainsway's Deep TMS System Wins FDA ApprovalIsraeli company Brainsway Ltd., which develops innovative devices for treatment of mental disorders using magnetic pulses, has announced that it has received US Food and Drug Administration (FDA) approval for its Deep TMS system. The system uses transcranial magnetic stimulation (TMS) for treating depression in patients who cannot be treated using standard methods.

     
  • NoCamels Team 11:15 am on April 17, 2012 Permalink | Reply
    Tags: brainsway, , TMS, Transcranial Magnetic Stimulation,   

    ‘Brainsway’: Successful Results In Depression Treatment Trial 

    Brainsway - News Flash - IsraelIsraeli developer of noninvasive medical devices for the treatment of neurological and psychopathological disorders, Brainsway, announced positive results in its trial for the treatment of severe depression. The treatment, which uses a Deep Transcranial Magnetic Stimulation (TMS) device, was found to be effective and safe – company announced. The trial included 250 patients and showed improvements among those treated with Deep TMS compared to the control group, based on the Hamilton Depression Rating Scale.

     
c
compose new post
j
next post/next comment
k
previous post/previous comment
r
reply
e
edit
o
show/hide comments
t
go to top
l
go to login
h
show/hide help
shift + esc
cancel